Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerWillemien J. van Driel, Gabe S. Sonke, Jacobus van der Velden et al.|New England Journal of Medicine|2018Cited by 1.4k
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJonathan A. Ledermann, Anna Fagotti, Xavier Matías‐Guiu et al.|Annals of Oncology|2024Cited by 277
Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune responseWillemien J. van Driel, Gert Jan Fleuren, Pancras C.W. Hogendoorn et al.|Human Pathology|1996Cited by 87
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)Stephanie N. Gregory, Carrie E. Ryan, Jonathan M. Hernandez et al.|Annals of Surgical Oncology|2022Cited by 3